Old Drugs, New Tricks

(Jan 8, 2016)

Breakthrough science in the longevity space doesn't always require the development of new medicines. In fact, there are significant advantages to repurposing medicines already in use, since some of the most expensive aspects of drug development lie in establishing human safety in the trial phase. Drugs already in use have a safety profile and a significant body of existing research to draw upon; further trials need focus mainly upon demonstrating efficacy against the new condition. This not only lowers costs for any sponsoring pharmaceutical company, but should deliver effective treatments to patients on a much shorter timescale.

One recent example is the asthma drug, montelukast, which is attracting…

Read more

Tags: longevity, research, regenerative medicine, cognitive impairment, diabetes

Find by key-word

Find by date

Find by tag (show all )